Arca Biopharma | ABIO - Despesas De Vendas E Administração

Preço das Ações
41.25
Mudança Diária
2.34 6.01%
Mensal
16.00%
Anual
233.74%
Q1 Previsão
37.74




Despesas De Vendas E Administração Alterar Data
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
Amgen USD 1.94B 237M 2025-12
Arca Biopharma USD 2.23M 1.08M 2025-12
Biogen USD 545.2M 38.6M 2025-09
Brainstorm Cell Therapeutics USD 1.07M 64K 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Capricor Therapeutics USD 1.92M 446.47K 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.21M 120K 2025-12
CSL USD 1.23B 498M 2025-12
Cytokinetics USD 91.72M 67.02M 2025-12
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Grifols EUR 320.45M 12.65M 2025-12
Laboratory Of America USD 538.6M 13.8M 2025-12
Myriad Genetics USD 122.3M 6.7M 2025-12
Otsuka Holdings JPY 278.3B 24.08B 2025-12
Pfizer USD 4.08B 894M 2025-12
United Therapeutics USD 190.6M 38.6M 2025-12